Aprogen Biologics Inc. (KRX:003060)
1,738.00
-62.00 (-3.44%)
Sep 1, 2026, 3:30 PM KST
-81.07% (1Y)
| Market Cap | 42.37B -65.0% |
| Revenue (ttm) | 86.18B +26.1% |
| Net Income | -78.30B |
| EPS | -5,853.51 |
| Shares Out | 23.54M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 158,112 |
| Open | 1,782.00 |
| Previous Close | 1,800.00 |
| Day's Range | 1,730.00 - 1,813.00 |
| 52-Week Range | 1,730.00 - 10,395.00 |
| Beta | -0.19 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |